Cargando…

Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study

BACKGROUND: Esophagogastric variceal bleeding is a serious complication of decompensated cirrhosis. Transjugular intrahepatic portal shunt (TIPS) is a salvage treatment with clear hemostatic results. However, various complications may occur after TIPS, including postoperative liver failure, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yunhai, Satapathy, Sanjaya K., Fernandes, Eduardo De Souza Martins, Ramírez-Fernández, Odin, Vitale, Alessandro, Chen, Zutao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652563/
https://www.ncbi.nlm.nih.gov/pubmed/36388791
http://dx.doi.org/10.21037/atm-22-4737
_version_ 1784828498154618880
author Yao, Yunhai
Satapathy, Sanjaya K.
Fernandes, Eduardo De Souza Martins
Ramírez-Fernández, Odin
Vitale, Alessandro
Chen, Zutao
author_facet Yao, Yunhai
Satapathy, Sanjaya K.
Fernandes, Eduardo De Souza Martins
Ramírez-Fernández, Odin
Vitale, Alessandro
Chen, Zutao
author_sort Yao, Yunhai
collection PubMed
description BACKGROUND: Esophagogastric variceal bleeding is a serious complication of decompensated cirrhosis. Transjugular intrahepatic portal shunt (TIPS) is a salvage treatment with clear hemostatic results. However, various complications may occur after TIPS, including postoperative liver failure, and the prognosis is very poor once occurs. Liver failure is a common symptom of severe liver disease with a high mortality rate. This study investigated the incidence of liver failure after TIPS treatment for varicose bleeding. METHODS: We analyzed the data of patients admitted to the First Affiliated Hospital of Soochow University between January 2013 and December 2018 with portal hypertension with an episode of acute gastroesophageal variceal bleeding. A total of 121 patients were referred to the regional liver unit for TIPS. Hepatic venous pressure gradient (HVPG) and clinical data were collected. Patients with incomplete data were excluded, and 93 patients were ultimately enrolled in the study. Primary outcomes were morbidity and hospital mortality within 4 weeks of surgery. The data were retrospectively and consecutively collected and evaluated by univariate and multivariate analyses to identify risk factors of liver failure. RESULTS: The patients included 58 males (62.37%) and 35 females (37.63%), and the mean age was 58.43±11.85 years. The main cause was hepatitis B virus (HBV), which was found in 50.54% of patient. The overall surgical success rate was 83.87% (78/93). Of 15 treatment-failure patients, 9 (9.68%) died in hospital. Four patients died of liver failure, accounting for 44.44% of postoperative all-cause deaths. Univariate logistic regression analysis showed that only hepatic venous pressure gradient (HVPG) was an independent risk factor for post-TIPS morbidity [relative risk (RR) 1.156; 95% confidence interval (CI): 1.041 to 1.283; P=0.006]. In addition, HVPG was an independent risk factor for hospital mortality within 4 weeks (RR 1.133; 95% CI: 1.021 to 0.539; P=0.016). CONCLUSIONS: Post-TIPS liver failure is a serious complication in patients with cirrhosis. Pre-TIPS HVPG level may be used as a predictor of potential short-term postoperative adverse events.
format Online
Article
Text
id pubmed-9652563
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96525632022-11-15 Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study Yao, Yunhai Satapathy, Sanjaya K. Fernandes, Eduardo De Souza Martins Ramírez-Fernández, Odin Vitale, Alessandro Chen, Zutao Ann Transl Med Original Article BACKGROUND: Esophagogastric variceal bleeding is a serious complication of decompensated cirrhosis. Transjugular intrahepatic portal shunt (TIPS) is a salvage treatment with clear hemostatic results. However, various complications may occur after TIPS, including postoperative liver failure, and the prognosis is very poor once occurs. Liver failure is a common symptom of severe liver disease with a high mortality rate. This study investigated the incidence of liver failure after TIPS treatment for varicose bleeding. METHODS: We analyzed the data of patients admitted to the First Affiliated Hospital of Soochow University between January 2013 and December 2018 with portal hypertension with an episode of acute gastroesophageal variceal bleeding. A total of 121 patients were referred to the regional liver unit for TIPS. Hepatic venous pressure gradient (HVPG) and clinical data were collected. Patients with incomplete data were excluded, and 93 patients were ultimately enrolled in the study. Primary outcomes were morbidity and hospital mortality within 4 weeks of surgery. The data were retrospectively and consecutively collected and evaluated by univariate and multivariate analyses to identify risk factors of liver failure. RESULTS: The patients included 58 males (62.37%) and 35 females (37.63%), and the mean age was 58.43±11.85 years. The main cause was hepatitis B virus (HBV), which was found in 50.54% of patient. The overall surgical success rate was 83.87% (78/93). Of 15 treatment-failure patients, 9 (9.68%) died in hospital. Four patients died of liver failure, accounting for 44.44% of postoperative all-cause deaths. Univariate logistic regression analysis showed that only hepatic venous pressure gradient (HVPG) was an independent risk factor for post-TIPS morbidity [relative risk (RR) 1.156; 95% confidence interval (CI): 1.041 to 1.283; P=0.006]. In addition, HVPG was an independent risk factor for hospital mortality within 4 weeks (RR 1.133; 95% CI: 1.021 to 0.539; P=0.016). CONCLUSIONS: Post-TIPS liver failure is a serious complication in patients with cirrhosis. Pre-TIPS HVPG level may be used as a predictor of potential short-term postoperative adverse events. AME Publishing Company 2022-10 /pmc/articles/PMC9652563/ /pubmed/36388791 http://dx.doi.org/10.21037/atm-22-4737 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Yao, Yunhai
Satapathy, Sanjaya K.
Fernandes, Eduardo De Souza Martins
Ramírez-Fernández, Odin
Vitale, Alessandro
Chen, Zutao
Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title_full Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title_fullStr Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title_full_unstemmed Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title_short Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
title_sort hepatic venous pressure gradient (hvpg) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652563/
https://www.ncbi.nlm.nih.gov/pubmed/36388791
http://dx.doi.org/10.21037/atm-22-4737
work_keys_str_mv AT yaoyunhai hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy
AT satapathysanjayak hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy
AT fernandeseduardodesouzamartins hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy
AT ramirezfernandezodin hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy
AT vitalealessandro hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy
AT chenzutao hepaticvenouspressuregradienthvpgpredictsliverfailureaftertransjugularintrahepaticportalshuntaretrospectivecohortstudy